This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gupta, S. Articles by Mukhtar, H. Search for Related Content PubMed PubMed Citation Articles by Gupta, S. Articles by Mukhtar, H.

Prostate Cancer Chemoprevention by Green Tea

In Vitro and in Vivo Inhibition of Testosterone-mediated Induction of Ornithine Decarboxylase¹

Department of Dermatology, Case Western Reserve University, Cleveland, Ohio 44106

Recently, we have shown that ornithine decarboxylase (ODC), a rate-controlling enzyme in the polyamine biosynthetic pathway, is overexpressed in prostate cancer (PCA) and prostatic fluid in humans (R. R. Mohan et al., Clin. Cancer Res., 5: 143–147, 1999). ODC is also characterized as an androgen-responsive gene, and the androgenic stimulation regulates the development and growth of both normal and tumorigenic prostate cells. Thus, chemopreventive approaches aimed toward the modulation of ODC could be effective against PCA. Green tea polyphenols (GTPs) possess strong chemopreventive properties against a variety of animal tumor models and in some human epidemiological studies. At least two epidemiological studies have suggested that people who consume tea regularly may have a decreased risk of PCA. In this study, we investigated the effect of GTPs against testosterone-mediated induction of ODC in human prostate carcinoma cells, LNCaP as an in vitro model, and in Cpb:WU rats and C57BL/6 mice as in vivo models. Treatment of LNCaP cells with testosterone resulted in induction of ODC activity in a dose-dependent manner. Pretreatment of the cells with GTPs resulted in a significant inhibition of testosterone-caused induction of ODC activity in a dose-dependent manner. Similar effects of GTPs were observed in anchorage-independent growth assay of LNCaP cells where pretreatment of the cells with GTP was found to result in dose-dependent inhibition of colony formation. Testosterone treatment of the cells resulted in a significant increase in the level of ODC mRNA, and this increase was almost completely abolished by prior treatment of the cells with GTPs. The administration of testosterone (10 mg/kg body weight, i.p.) to sham-operated and castrated Cpb:WU rats resulted in 2- and 38-fold increases in ODC activity, respectively, in the ventral prostate. Oral feeding of 0.2% GTPs in drinking water for 7 days before testosterone administration resulted in 20 and 54% decreases in testosterone-caused induction of ODC activity in sham-operated and castrated rats, respectively. Similar results were obtained with C57BL/6 mice, where testosterone treatment at similar dosage resulted in a 2-fold increase in ODC activity in the ventral prostate and prior oral feeding with 0.2% GTPs resulted in 40% inhibition in this induction.

This article has been cited by other articles:

				D. N. Syed, N. Khan, F. Afaq, and H. Mukhtar Chemoprevention of Prostate Cancer through Dietary Agents: Progress and Promise Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2193 - 2203. [Abstract] [Full Text] [PDF]

				R. P Singh and R. Agarwal Mechanisms of action of novel agents for prostate cancer chemoprevention. Endocr. Relat. Cancer, September 1, 2006; 13(3): 751 - 778. [Abstract] [Full Text] [PDF]

				M. Tascilar, F. A. de Jong, J. Verweij, and R. H. J. Mathijssen Complementary and Alternative Medicine During Cancer Treatment: Beyond Innocence Oncologist, July 1, 2006; 11(7): 732 - 741. [Abstract] [Full Text] [PDF]

				H.-H. Lee, C.-T. Ho, and J.-K. Lin Theaflavin-3,3'-digallate and penta-O-galloyl-{beta}-D-glucose inhibit rat liver microsomal 5{alpha}-reductase activity and the expression of androgen receptor in LNCaP prostate cancer cells Carcinogenesis, July 1, 2004; 25(7): 1109 - 1118. [Abstract] [Full Text] [PDF]

				V. M. Adhami, N. Ahmad, and H. Mukhtar Molecular Targets for Green Tea in Prostate Cancer Prevention J. Nutr., July 1, 2003; 133(7): 2417S - 2424. [Abstract] [Full Text] [PDF]

				D. C. Malins, P. M. Johnson, E. A. Barker, N. L. Polissar, T. M. Wheeler, and K. M. Anderson Cancer-related changes in prostate DNA as men age and early identification of metastasis in primary prostate tumors PNAS, April 29, 2003; 100(9): 5401 - 5406. [Abstract] [Full Text] [PDF]

				J. Hong, H. Lu, X. Meng, J.-H. Ryu, Y. Hara, and C. S. Yang Stability, Cellular Uptake, Biotransformation, and Efflux of Tea Polyphenol (-)-Epigallocatechin-3-Gallate in HT-29 Human Colon Adenocarcinoma Cells Cancer Res., December 15, 2002; 62(24): 7241 - 7246. [Abstract] [Full Text] [PDF]

				A. Kazi, D. M. Smith, Q. Zhong, and Q. P. Dou Inhibition of Bcl-XL Phosphorylation by Tea Polyphenols or Epigallocatechin-3-Gallate Is Associated with Prostate Cancer Cell Apoptosis Mol. Pharmacol., October 1, 2002; 62(4): 765 - 771. [Abstract] [Full Text] [PDF]

				S. Gupta, K. Hastak, N. Ahmad, J. S. Lewin, and H. Mukhtar Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols PNAS, August 10, 2001; (2001) 171326098. [Abstract] [Full Text] [PDF]

				J. Brown, T. Byers, K. Thompson, B. Eldridge, C. Doyle, A. M. Williams, and American Cancer Society Workgroup on Nutrition and Nutrition During and After Cancer Treatment: A Guide for Informed Choices by Cancer Survivors CA Cancer J Clin, May 1, 2001; 51(3): 153 - 181. [Abstract] [Full Text] [PDF]

				S. H. Mitchell, W. Zhu, and C. Y. F. Young Resveratrol Inhibits the Expression and Function of the Androgen Receptor in LNCaP Prostate Cancer Cells Cancer Res., December 1, 1999; 59(23): 5892 - 5895. [Abstract] [Full Text] [PDF]

				S. Gupta, K. Hastak, N. Ahmad, J. S. Lewin, and H. Mukhtar Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols PNAS, August 28, 2001; 98(18): 10350 - 10355. [Abstract] [Full Text] [PDF]